Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1GK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,111
Award facts
- Contract value 100% obligated
- $62,110.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $62,110.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 4,570,560 units of Dupixent 300 mg/2 ml pens on January 20, 2026, with completion targeted for January 21, 2026. This delivery order was awarded without set-aside designations on a competitive basis and will be performed at the awardee's Conshohocken, Pennsylvania facility. Dupixent (dupilumab) is a biologic immunosuppressant medication commonly prescribed for moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis, making this a critical pharmaceutical supply for military and federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support for military healthcare programs, covering specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor registered in the System for Award Management, which also holds an extended IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 2031, demonstrating the company's substantial role in federal medical procurement.
Quick answers
Who was awarded contract SPE2DR26FA1GK?
SPE2DR26FA1GK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FA1GK worth?
The government has obligated $62,111 on SPE2DR26FA1GK.
Is contract SPE2DR26FA1GK an order under another contract?
Yes. SPE2DR26FA1GK is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1GK competed?
The extent of competition for SPE2DR26FA1GK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award